Sana Biotechnology Inc

-0.39 (-5.14%)
Earnings Announcements

Sana Biotechnology Inc - QTRLY Loss Per Share $0.39

Published: 08/04/2022 21:28 GMT
Sana Biotechnology Inc (SANA) - Sana Biotechnology Reports Second Quarter 2022 Financial Results and Business Updates.
Expect Cash Runway Into 2025.
Expect to File Inds This Year for Sc291 and Sg295.
Q2 2022 Cash Position of $579.6 Million.
Qtrly Loss per Share $0.39.
Q2 Earnings per Share View $-0.51 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.49

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.64

More details on our Analysts Page.